Lv5
1300 积分 2023-08-07 加入
Targeting Focal adhesion kinase (FAK) in cancer therapy: A recent update on inhibitors and PROTAC degraders
11小时前
已完结
Current senolytics: Mode of action, efficacy and limitations, and their future
16天前
已完结
A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice
16天前
已完结
Development of a high-yield recombinant clone for the enhanced production of a long-acting Glucagon like Peptide-1 analogue with improved biological efficacy
1个月前
已完结
Identification of a Novel 2,8-Diazaspiro[4.5]decan-1-one Derivative as a Potent and Selective Dual TYK2/JAK1 Inhibitor for the Treatment of Inflammatory Bowel Disease
7个月前
已完结
Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo Activity
7个月前
已完结
Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?
7个月前
已完结
Remibrutinib, a Novel Bruton Tyrosine Kinase Inhibitor, Exhibits Improved Target Selectivity and Potency in Vitro
7个月前
已完结
Harmonized analysis of PBMC by mass cytometry
7个月前
已完结
Peripheral blood mononuclear cell- transcriptome signatures of atopic dermatitis and prediction for the efficacy of dupilumab
7个月前
已完结
The fountain of youth of mitochondrial research
皖公网安备34019202002308
